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Abstract
Retrovirus packaging cell lines that express the Moloney murine leukemia virus gag, pol, and env genes and a retroviral vector genome
can produce virus particles that are capable of transducing cells. Normally if the packaging cell line does not produce a functional viral
fusion glycoprotein, such as the retroviral envelope protein or a foreign viral glycoprotein, then the viruses will be incapable of transducing
cells. We have found that incubating envelope protein-deficient virus particles bound to cells with chlorpromazine leads to transduction.
Chlorpromazine (CPZ) is a membrane-active reagent that is commonly used to induce the hemifusion to fusion transition when membrane
fusion is mediated by partially defective viral glycoproteins. The concentration and pH dependence of the promotion of transduction by CPZ
is consistent with a role for CPZ micelle formation in viral entry. These data indicate that caution is warranted when experiments concerning
membrane fusion completion promoted by CPZ are analyzed.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Recombinant viruses derived from the Moloney murine
leukemia virus (Mo-MuLV), a gammaretrovirus, are com-
monly used for gene transfer and gene therapy applications.
The Mo-MuLV envelope (Env) protein is also a model for
understanding the structural and biochemical bases of mem-
brane fusion and viral entry. The envelope protein precursor
is proteolytically processed into two subunits (Henderson et
al., 1984; Witte et al., 1977), SU and TM, which are linked
through a disulfide bond (Pinter and Fleissner, 1977; Pinter
et al., 1997, 1978). SU is found exclusively on the outside
of the retroviral particle, whereas TM possesses extrapar-
ticle, a membrane-spanning, and intraparticle domains (Pin-
ter and Honnen, 1983). The TM protein possesses at its
amino terminus a sequence that is believed to encode the
fusion peptide, which, upon exposure, promotes the first
steps in the membrane fusion process that occurs during
viral entry (Jones and Risser, 1993; Taylor et al., 2001; Zhu
et al., 1998). The membrane-spanning domain of TM has
recently been shown also to participate in the process of
membrane fusion (Taylor and Sanders, 1999). A current
model is that the binding of SU to the cellular receptor
results in a thiol–disulfide exchange reaction leading to the
elimination of the disulfide bond between the SU and TM
subunits and consequent exposure of the TM fusion peptide
that promotes membrane fusion and viral entry (Pinter et al.,
1997; Sanders, 2000).
As part of our investigations of the biochemical and
biophysical basis of Mo-MuLV Env-mediated membrane
fusion, we were interested in utilizing the membrane-active
tertiary amine chlorpromazine (CPZ) as a tool for under-
standing the biophysical transitions that occurred during the
fusion process. In its neutral form CPZ is membrane per-
meable and can translocate from the outer leaflet of a cell
membrane to the inner leaflet. Upon translocation CPZ
becomes charged and remains kinetically trapped in the
inner leaflet of the membrane (Cohen and Melikyan, 1998).
CPZ has been utilized in studying the transition from the
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presumed hemifusion intermediate state in viral glycopro-
tein-mediated membrane fusion to complete membrane fu-
sion, because it induces positive curvature in the inner
leaflet of the membrane and thereby promotes fusion pore
formation and ultimately the completion of the membrane
fusion process (Melikyan et al., 1997).
CPZ has commonly been used in experiments concern-
ing cell–cell fusion mediated by viral glycoproteins to gain
evidence about hemifusion intermediates (Chernomordik et
al., 1998; Markosyan et al., 2000; Melikyan et al., 1997,
1999). When cells have undergone hemifusion, the addition
of CPZ will promote complete fusion (Cohen and Melikyan,
1998). On the other hand, if hemifusion has not occurred,
the addition of CPZ will not promote fusion. We have found
that recombinant Mo-MuLV particles that do not bear a
viral envelope protein and are consequently incapable of
transducing cells can introduce genetic material into a cell
in a stable fashion when the virus and cells are incubated
with CPZ. These data suggest that caution should be exer-
cised when interpreting the effects of CPZ on viral glyco-
protein-mediated membrane fusion.
Results
Addition of CPZ to NIH 3T3 cells incubated with Mo-
MuLV lacking an envelope protein induces transduction
Recombinant Mo-MuLV particles carrying a retroviral
vector encoding a nuclear-localized Escherichia coli -ga-
lactosidase but lacking a viral envelope protein are pro-
duced by gpnlslacZ cells (Sharkey et al., 2001). These virus
particles are incapable of transducing any of a number of
cell lines that we have tested, including mouse fibroblast
NIH 3T3 cells, which are susceptible to wild-type Mo-
MuLV.
Mo-MuLV particles from gpnlslacZ cells or from
gpnlslacZ cells that have been transfected with penv 1 min,
which encodes the wild-type Mo-MuLV Env, were incu-
bated with NIH 3T3 cells for 4 h. The cells were then treated
with 0.5 mM CPZ for 1 min and incubated with normal
medium for 48 h. The cells were stained with the -galac-
tosidase detection reagent X-gal 48 h after the CPZ treat-
ment. The level of transduction was evaluated by determin-
ing the percentage of cells expressing -galactosidase
activity. It was found that CPZ did not affect the level of
transduction (approximately 70% of the NIH 3T3 cells were
stained) by Mo-MuLV particles bearing the Mo-MuLV Env
protein. CPZ treatment did, however, promote transduction
of on average 1% of the NIH 3T3 cells by the Mo-MuLV
particles lacking an envelope protein (Mo-MuLV/Env). The
percentage of cells that were transduced was stable as they
were passaged for 2 weeks, which indicates that retroviral
transduction and not pseudotransduction (Gallardo et al.,
1997; Liu et al., 1996) was occurring. It should be noted that
the level of CPZ-mediated transduction was consistently
less than that of Mo-MuLV Env-mediated transduction.
There was also some variation in the absolute level of
CPZ-mediated transduction from experiment to experiment.
To confirm that authentic transduction by Mo-MuLV
particles lacking an envelope protein was occurring an en-
richment of transduced cells was performed. The cells were
incubated with the fluorogenic -galactosidase substrate
fluorescein di--D-galactopyranoside (FDG) and cells that
were positive for fluorescence were sorted by flow cytom-
etry and further passaged. The nlslacZ gene, amplified by
the polymerase chain reaction, could be detected in the
DNA from cells transduced by envelope-bearing Mo-MuLV
or by Mo-MuLV/Env in the presence of 0.5 mM CPZ but
not from cells that were incubated with 0.5 mM CPZ in the
absence of Mo-MuLV particles. These data indicate that the
stable transduction of the cells by Mo-MuLV/Env was
promoted by CPZ incubation (Fig. 1).
Virus and CPZ concentration dependence of transduction
We wished to investigate the dependence of transduction
by Mo-MuLV lacking an envelope protein upon the con-
centration of virus particles. As the virus is diluted, trans-
duction decreased correspondingly (Fig. 2), indicating that
there are no threshold or higher order effects of viral con-
centration upon CPZ-mediated transduction.
Increasing the concentration of CPZ used for treating
cells incubated with virus lacking an envelope protein re-
sulted in an increased percentage of cells transduced (Fig.
3). These data are consistent with a role for CPZ micelle
formation in the promotion of transduction (Wajnberg et al.,
1988). Another means of manipulating the concentration of
CPZ in the membrane-permeable neutral form is by con-
trolling the pH of the medium. Decreasing the pH decreases
the concentration of the neutral form of CPZ and decreases
CPZ-mediated transduction (Fig. 4).
Fig. 1. Detection of retrovial vector DNA in cells transduced by Mo-MuLV
lacking an envelope protein in the presence of CPZ. DNA encoding the
nlslacZ gene amplified from cells transduced by recombinant Mo-MuLV or
Mo-MuLV lacking an envelope protein (Mo-MuLV/Env) was analyzed.
The nlslacZ gene is detected in NIH 3T3 cells incubated with Mo-MuLV/
Env and 0.5 mM CPZ but not in cells incubated with 0.5 mM CPZ alone.
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It is noteworthy that an important limitation on utilizing
CPZ for the promotion of transduction is the cellular tox-
icity associated with longer incubations with or higher con-
centrations of CPZ (data not shown). Experiments con-
ducted with virus lacking an envelope protein in serum-free
medium demonstrated that 1% transduction by Mo-MuLV/
Env could be demonstrated at a concentration of 0.1 mM
CPZ. At 0.2 mM CPZ nearly 100% cell death was observed.
The mechanism of protection by serum of the cells against
the toxic effects of CPZ is uncertain, although it is possible
that the effective CPZ concentration is reduced through its
binding to serum proteins.
Polybrene does not facilitate CPZ-promoted transduction
Polybrene (hexadimethrine bromide) is a polycationic
reagent that facilitates viral infection in vitro. It was of
interest to determine whether polybrene affected CPZ-pro-
moted transduction by recombinant Mo-MuLV lacking a
viral envelope protein. Virus from gpnlslacZ cells express-
ing either the wild-type envelope protein or no envelope
protein was incubated with NIH 3T3 cells in the presence of
various concentrations of polybrene. There was a clear ef-
fect of polybrene concentration on transduction by virus
bearing the Mo-MuLV Env protein (Fig. 5A). However, the
level of transduction by Mo-MuLV/Env promoted by 0.5
mM CPZ was independent of polybrene concentration (Fig.
5B), indicating that the effect of polybrene requires the viral
glycoprotein and that the mechanisms of membrane fusion
promotion by viral Env protein and CPZ are distinct.
Discussion
We demonstrate here that chlorpromazine can promote
the transduction of cells by recombinant Mo-MuLV virus
particles that do not bear a viral envelope protein. The effect
of chlorpromazine concentration and pH upon transduction
efficiencies is consistent with a role for CPZ micelle for-
mation in the process (Wajnberg et al., 1988), although
there is a distinct possibility that the effective CPZ concen-
tration is reduced by the presence of serum. The concentra-
tion dependence of the effects we observed is similar to that
seen for the induction of the transition from hemifusion to
complete fusion seen in earlier studies (Melikyan et al.,
1997). It has previously been demonstrated that the trans-
fection reagent Lipofectin can have a similar capacity to
promote transduction by Mo-MuLV particles that lack an
Fig. 2. Dependence of CPZ-induced transduction by Mo-MuLV lacking an
envelope protein on virus concentration. Various concentrations of Mo-
MuLV lacking an envelope protein were incubated with NIH 3T3 cells for
4 h prior to treatment with 0.5 mM CPZ. The level of transduction was
determined 32 h after treatment by staining with X-gal. The data are
representative of three independent experiments.
Fig. 3. CPZ concentration dependence of transduction by Mo-MuLV lack-
ing an Env. NIH 3T3 cells were incubated with Mo-MuLV lacking an Env
for 4 h prior to treatment with various concentrations of CPZ for 1 min. The
level of transduction was determined 32 h after treatment. The data are
representative of three independent experiments.
Fig. 4. Dependence of CPZ-induced transduction by Mo-MuLV lacking an
envelope protein upon pH. Mo-MuLV lacking an envelope protein was
incubated with NIH 3T3 cells for 4 h. The cells were then incubated with
0.5 mM CPZ in medium at the indicated pH for 1 min. The level of
transduction was determined 32 h after treatment.
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envelope protein (Sharma et al., 1997). It is noteworthy that,
as we found with CPZ-promoted transduction, Lipofectin-
promoted transduction is not enhanced by the presence of
polybrene (Sharma et al., 1997). This contrasts with the
finding that the promotion of transduction by recombinant
retrovirus lacking a viral envelope protein by incubation
with vesicles bearing the vesicular stomatitis virus G protein
does require polybrene (Sharma et al., 2000). Our data
provide further support for the idea that polybrene promotes
specifically entry mediated by viral fusion proteins.
The entry of an enveloped virus into a cell can be con-
ceptually divided into a number of steps. There is the pri-
mary binding of a virus to a cell surface. This is normally
considered the consequence of the binding of a viral glyco-
protein to a receptor on a cell surface. However, the process
is known to be more complex in a number of viral systems.
There may be an interaction between the virus and an
attachment factor [CD4 for the human immunodeficiency
virus (HIV)] that leads to the association with the authentic
receptor (in the case of HIV, a chemokine receptor). The
role of the attachment factor may include the reduction of
the three-dimensional search for the receptor that actually
leads to viral entry to a two-dimensional problem. It has
been suggested that the initial association of Mo-MuLV
with a cell surface is independent of the Env protein (Piz-
zato et al., 1999). It may be that such binding is responsible
for the interaction that leads to CPZ-promoted transduction.
After binding the conformational changes that lead to
membrane fusion must take place. These may transpire after
endocytosis of the virus particle and exposure of the viral
glycoprotein to the low endocytic pH or they may result
directly from receptor-induced conformational changes that
occur at the cell surface, as suggested for Mo-MuLV and
retroviruses with homologous envelope proteins (Sanders,
2000). It has been demonstrated that CPZ can induce the
uptake of a soluble dye into large unilamellar vesicles,
perhaps by inducing endovesiculation, although the promo-
tion of fusion between a CPZ micelle and the large unila-
mellar vesicle can not be excluded (Tedesco and Matile,
1999). It is possible that in our experiments CPZ is inducing
endocytosis of the Mo-MuLV particles and that membrane
fusion ensues. Alternatively CPZ may promote membrane
fusion directly between the virus particle and the cell mem-
brane.
It is known that recombinant retroviruses can incorporate
the glycoproteins of other viruses and utilize them for en-
trance into cells (Jeffers et al., 2002; Sanders, 2002; Sharkey
et al., 2001; Yee et al., 1994). It cannot currently be ruled
out that a cellular protein that is capable of promoting
hemifusion between the viral envelope and the cell mem-
brane is incorporated into the recombinant Mo-MuLV par-
ticle and that CPZ merely promotes the transition from
hemifusion to full fusion as it is proposed to do in the case
of mutants of the influenza virus hemagglutinin (Cherno-
mordik et al., 1998; Markosyan et al., 2000; Melikyan et al.,
1997, 1999). We do not have any evidence to support this
model and do not favor it.
It should be kept in mind that most of the previous
experiments with CPZ concern cell– cell fusion mediated
by viral envelope glycoproteins, whereas our studies in-
volved viral– cell fusion. There are potential differences
in the processes of cell– cell and virus– cell fusion. Re-
cently, however, it has been argued that the promotion of
infection by incubation of a recombinant vesicular sto-
matitis virus bearing only the ectodomain membrane-
proximal, transmembrane, and cytoplasmic domains of
the vesicular stomatitis virus G (VSV-G) protein with
chlorpromazine provides evidence that the truncated
VSV-G protein was able to induce hemifusion in the
absence of chlorpromazine (Jeetendra et al., 2002). Our
data indicate that this conclusion might not be warranted.
Overall, in the interpretation of experiments involving
chlorpromazine, it seems prudent to regard it for now as
Fig. 5. Polybrene dependence of transduction by virus bearing the Mo-
MuLV Env or lacking an Env. NIH 3T3 cells were incubated with virus
bearing the Mo-MuLV Env (A) or lacking an Env (B) in the presence of
various concentrations of polybrene for 4 h. The NIH 3T3 cells that were
incubated with virus lacking an Env were then treated with 0.5 mM CPZ
for 1 min. The NIH 3T3 cells that were incubated with recombinant
Mo-MuLV bearing Env were treated with 0.5 mM CPZ (dashed line) or
untreated (solid line). Thirty-two hours postinfection, the level of trans-
duction was determined. The data are representative of three independent
experiments.
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an agent that can directly promote viral– cell membrane
fusion and virus entry.
Materials and methods
Cell lines and cell culture
Mouse NIH 3T3 fibroblast cells were grown in Dulbec-
co’s modified Eagle’s medium (D-MEM; Sigma) with 10%
calf serum (CS; Gibco-BRL), streptomycin (0.1 mg/ml),
and penicillin (10 U/ml) (PS; Sigma) (D-MEM CS/PS). The
gpnlslacZ cells (which produce envelope protein-deficient
replication-incompetent Mo-MuLV particles carrying
MFG.S-nlsLacZ, a retroviral vector that encodes a nuclear-
localized -galactosidase (Ory et al., 1996; Sharkey et al.,
2001)) were grown in D-MEM with 10% fetal bovine serum
(FBS; Sigma) and PS (D-MEM FBS/PS).
Viral transduction assays
The penv1min plasmid encoding for the Mo-MuLV en-
velope protein was transiently transfected into gpnlslacZ (1
 106) cells following the protocol described previously
(Taylor and Sanders, 1999). Medium from the transiently
transfected gpnlslacZ cells was removed 32 h posttransfec-
tion and filtered through a 0.45-m filter. It was then incu-
bated with 1  106 NIH 3T3 cells in the presence or the
absence of 8 g/ml of hexadimethrine bromide (polybrene)
for 4 h. The recombinant virus-containing medium was
removed and the NIH 3T3 cells were treated with or without
0.5 mM CPZ (Sigma) in DMEM-CS/PS for 1 min. The cells
were then washed with D-MEM CS/PS media and subse-
quently incubated with fresh D-MEM CS/PS media at 37°C
with 5% CO2 for 32 h before staining with X-gal as de-
scribed previously (Taylor and Sanders, 1999). The percent-
age of transduction was determined by counting the number
of blue cells with respect to the total number of cells. Each
experiment was performed at least twice. The data presented
are normally from a single experiment but are representa-
tive.
Chlorpromazine studies
Virus from gpnlslacZ cells (1  106) that were tran-
siently transfected with penv1min, the plasmid encoding the
wild-type Mo-MuLV envelope protein, or that were mock
transfected was collected and used to infect NIH 3T3 cells
in the presence or the absence of various concentrations of
polybrene for 4 h at 37°C with 5% CO2. Four hours postin-
fection the cells were treated with various concentrations of
chlorpromazine (CPZ, Sigma) for 1 min in D-MEM CS/PS
media at the appropriate pH. The cells were washed in fresh
D-MEM CS/PS media and subsequently incubated at 37°C
with 5% CO2 for 32 h before staining with X-gal. Each
experiment was performed at least twice. The data presented
are normally from a single experiment but are representa-
tive. Incubation of the cells with virus in serum-free me-
dium (D-MEM) was conducted similarly, but toxicity was
observed when CPZ concentrations higher than 0.1 mM
were present.
Fluorescence-activated cell sorting of transduced cells
NIH 3T3 cells transduced with MFG.S-nlsLacZ were
passaged for 2 weeks. The cells were then stained with the
fluorogenic -galactosidase substrate FDG. The cells were
suspended at 107 cells/ml in staining media (PBS, 4% FBS,
10 mM HEPES, pH 7.4, 300 M chloroquine). After warm-
ing of the suspended cells at 37°C for 20 min, the cells were
incubated with 2 mM FDG at 37°C for 1 min. The reaction
was stopped by the addition of staining medium containing
1.5 M propidium iodine and 300 M chloroquine at 4°C.
The stained cells were kept on ice during sorting. Trans-
duced cells were sorted by fluorescence-activated cell sort-
ing with a Coulter Epics Elite cell sorter using a 630-nm
band pass filter and a 488-nm air-cooled argon laser. The
cells that were positive for fluorescence were grown for an
additional 4 weeks before detection of retroviral DNA was
attempted.
Detection of retroviral DNA in stable transduced cells
DNA from nontransduced and sorted transduced NIH
3T3 cells was prepared by phenol:chloroform extraction. A
1.9-kb C terminal portion of the nlslacZ gene was detected
by two rounds of amplification by the polymerase chain
reaction (PCR) utilizing the Taq DNA Core Polymerase
System (Qiagen) with the following primers: forward, 5
GATTGAAGCAGAAGCCTGCG 3; reverse, 5 GTTTC-
CATCAGTTGCTGTTG 3. Amplification of the Rapsn
acetylcholine receptor-associated protein (43K) gene was
used as a control (Williams et al., 2003). PCR products were
resolved by agarose gel electrophoresis.
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